Get started
Author

Wandini Lutchmun

Chronic diseases and multi-morbidity in persons experiencing homelessness: results from a cross-sectional study conducted at three humanitarian clinics in Germany in 2020
2022 · Wandini Lutchmun, Janina Gach, et al. · BMC Public Health · 19
PDF
Early Depressing Effect on Abundancy and Diversity of Sputum Microbiome Followed by Recovery During Anti-Tuberculosis Treatment: A Multi-Regimen Analysis of the High-Rifampicin II- and Multi-Arm-Multi-Stage Clinical Trials
2022 · Emmanuel Musisi, Adam Wyness, et al. · The Lancet Microbe · 11
PDF
Mental health of people with limited access to health services: a retrospective study of patients attending a humanitarian clinic network in Germany in 2021
2023 · Kashung Annie Mugambwa, Wandini Lutchmun, et al. · BMC Psychiatry · 7
PDF
First-in-human study of the benzothiazinone and DprE1 inhibitor BTZ-043, a novel drug candidate for the treatment of Tuberculosis
2025 · Wandini Lutchmun, Norbert Heinrich, et al. · JAC-Antimicrobial Resistance · 6
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB
2025 · Simon E Koele, Krista Stoycheva, et al. · Journal of Antimicrobial Chemotherapy · 5
PDF
Proceedings from the CIH-LMU 2021 Symposium: “Global Health Perspectives: Climate Change & Migration”
2021 · Wandini Lutchmun, Aikins Ablorde, et al. · BMC Proceedings · 2
PDF
The importance of getting the dose right in the treatment of tuberculosis
2025 · Andrii Dudnyk, Wandini Lutchmun, et al. · Breathe
Chronic diseases and multi-morbidity in persons experiencing homelessness: a cross-sectional study
2022 · W Lutchmun, G Froeschl, et al. · European Journal of Public Health
PDF
Works count: 9
Citation count: 50
H-index: 5
I10-index: 2
Year
Topic
Type